Hca Healthcare, Inc. HCA
We take great care to ensure that the data presented and summarized in this overview for HCA Healthcare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HCA
View all-
Vanguard Group Inc Valley Forge, PA16MShares$4.85 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY14.9MShares$4.49 Billion0.11% of portfolio
-
Sanders Capital, LLC West Palm Beach, FL11.5MShares$3.49 Billion6.82% of portfolio
-
State Street Corp Boston, MA8.32MShares$2.52 Billion0.14% of portfolio
-
Wellington Management Group LLP Boston, MA7.05MShares$2.13 Billion0.51% of portfolio
-
First Eagle Investment Management, LLC4.48MShares$1.36 Billion3.78% of portfolio
-
Royal Bank Of Canada Toronto, A64.21MShares$1.27 Billion0.36% of portfolio
-
Geode Capital Management, LLC Boston, MA3.82MShares$1.16 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC3.43MShares$1.04 Billion0.12% of portfolio
-
Capital World Investors Los Angeles, CA2.91MShares$880 Million0.19% of portfolio
Latest Institutional Activity in HCA
Top Purchases
Top Sells
About HCA
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Insider Transactions at HCA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 14
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
1,474
-13.49%
|
$526,218
$357.99 P/Share
|
Nov 14
2024
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,902
-44.3%
|
$7,211,190
$345.51 P/Share
|
Nov 14
2024
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,600
+43.69%
|
$3,696,600
$101.16 P/Share
|
Nov 14
2024
|
Jon M Foster EVP and COO |
BUY
Bona fide gift
|
Indirect |
19,955
+26.43%
|
-
|
Nov 14
2024
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Direct |
19,955
-34.69%
|
-
|
Nov 14
2024
|
Jon M Foster EVP and COO |
BUY
Other acquisition or disposition
|
Indirect |
9,502
+12.83%
|
$3,344,704
$352.74 P/Share
|
Nov 14
2024
|
Jon M Foster EVP and COO |
SELL
Other acquisition or disposition
|
Direct |
9,502
-23.73%
|
$3,344,704
$352.74 P/Share
|
Nov 14
2024
|
Erol R Akdamar Group President |
SELL
Open market or private sale
|
Direct |
2,900
-29.77%
|
$1,023,700
$353.0 P/Share
|
Nov 14
2024
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Open market or private sale
|
Direct |
3,897
-6.89%
|
$1,363,950
$350.0 P/Share
|
Nov 12
2024
|
Erol R Akdamar Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,257
-51.29%
|
$3,589,950
$350.53 P/Share
|
Nov 12
2024
|
Erol R Akdamar Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$1,360,000
$68.96 P/Share
|
Nov 12
2024
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
4,103
-6.76%
|
$1,436,050
$350.53 P/Share
|
Nov 12
2024
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+11.64%
|
$544,000
$68.96 P/Share
|
Nov 11
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,236
-22.85%
|
$1,155,252
$357.99 P/Share
|
Nov 11
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,710
+24.96%
|
$814,830
$173.12 P/Share
|
Oct 30
2024
|
Patricia F Elcan > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,021,199
+14.38%
|
$368,652,839
$361.55 P/Share
|
Oct 30
2024
|
Patricia F Elcan > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,021,199
-51.82%
|
$368,652,839
$361.55 P/Share
|
Sep 12
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
8,358
-21.97%
|
$3,217,830
$385.42 P/Share
|
Sep 10
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,722
-26.51%
|
$5,296,692
$386.43 P/Share
|
Sep 10
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,080
+29.9%
|
$3,201,600
$145.24 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 212K shares |
---|---|
Other acquisition or disposition | 1.03M shares |
Exercise of conversion of derivative security | 264K shares |
Bona fide gift | 89.4K shares |
Other acquisition or disposition | 1.03M shares |
---|---|
Payment of exercise price or tax liability | 225K shares |
Bona fide gift | 95.8K shares |
Open market or private sale | 72K shares |